Search - tctmd.com

Displaying 1 - 20 of 45

Sort: Relevancy | Date

Presentation TCT 2016

Intermediate-Risk Studies II: Updates From SURTAVI

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Jeffrey J. Popma

October 30, 2016

News Daily News

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

L.A. McKeown

August 24, 2016

Presentation TVT 2016

Updates From SURTAVI in Intermediate-Risk Patients

Presenter: Jeffrey J. Popma

June 16, 2016

News Daily News

研究确定患者使用 Sapien 3 出现新传导异常、需要心脏起搏器置入的预测因素

L.A. McKeown

February 07, 2016

News Daily News

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

L.A. McKeown

February 07, 2016

Presentation TCT 2015

Status Update on Moderate-Risk TAVR RCTs 2: SURTAVI

Presenter: Martin B. Leon, Neil E. Moat, Patrick W. Serruys

October 11, 2015

News Conference News TCT 2015

Asian TAVR Registry Shows Good Procedural and Clinical Results

October 11, 2015

News Daily News

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

October 01, 2015

News Daily News

En los Albores de la TAVR, No Hubo Más Mortalidad en Pacientes tratados en Centros No Participantes en Ensayos

October 01, 2015

News Daily News

El Mejor Grado de Sobredimensionamiento Varía en función del Dispositivo TAVR

Caitlin E. Cox

April 17, 2015

News Daily News

Best Degree of Oversizing Varies by TAVR Device

Caitlin E. Cox

April 17, 2015

News Daily News

After Propensity Matching, Early Mortality Risk Still Evident for Transapical TAVR

Todd Neale

April 10, 2015

News Conference News ACC 2015

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Todd Neale

March 15, 2015

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

Advertisement

Intermediate-Risk Studies II: Updates From SURTAVI

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

Updates From SURTAVI in Intermediate-Risk Patients

研究确定患者使用 Sapien 3 出现新传导异常、需要心脏起搏器置入的预测因素

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

Status Update on Moderate-Risk TAVR RCTs 2: SURTAVI

Asian TAVR Registry Shows Good Procedural and Clinical Results

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

En los Albores de la TAVR, No Hubo Más Mortalidad en Pacientes tratados en Centros No Participantes en Ensayos

El Mejor Grado de Sobredimensionamiento Varía en función del Dispositivo TAVR

Best Degree of Oversizing Varies by TAVR Device

After Propensity Matching, Early Mortality Risk Still Evident for Transapical TAVR

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

TCT Course Director Outlines Current TAVR Controversies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content